Protagonist Therapeutics, Inc. (PTGX)
100.79
-3.18
(-3.06%)
USD |
NASDAQ |
May 07, 10:43
Protagonist Therapeutics Free Cash Flow : -117.90M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 17.80B |
| AbbVie, Inc. | 17.82B |
| Insmed, Inc. | -997.58M |
| Madrigal Pharmaceuticals, Inc. | -275.41M |
| PTC Therapeutics, Inc. | 411.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -48.94M |
| Cash from Investing (Quarterly) | 90.89M |
| Cash from Financing (Quarterly) | 23.37M |
| Free Cash Flow Per Share (Quarterly) | -0.6974 |
| Free Cash Flow to Equity (Quarterly) | -48.61M |
| Free Cash Flow to Firm (Quarterly) | -49.16M |
| Free Cash Flow Yield | -1.79% |